Real-World Outcome of Treatment with Single-Agent Ibrutinib in Italian Patients with Chronic Lymphocytic Leukemia: Final Results of the EVIdeNCE Study
FR Mauro, PR Scalzulli, L Scarfò, C Minoia, R Murru… - Cancers, 2024 - mdpi.com
Simple Summary In clinical trials, ibrutinib was found to be effective and well-tolerated in
patients with chronic lymphocytic leukemia (CLL). To confirm these findings, data on …
patients with chronic lymphocytic leukemia (CLL). To confirm these findings, data on …